المؤلفون: Albasanz-Puig, Adaia, Gudiol, Carlota, Parody, Rocio, Tebe, Cristian, Akova, Murat, Araos, Rafael, Bote, Anna, Brunel, Anne-Sophie, Calik, Sebnem, Drgona, Lubos, Garcia, Estefania, Hemmati, Philipp, Herrera, Fabian, Ibrahim, Karim Yaqub, Isler, Burcu, Kanj, Souha, Kern, Winfried, Maestro de la Calle, Guillermo, Manzur, Adriana, Ivan Marin, Jorge, Marquez-Gomez, Ignacio, Martin-Davila, Pilar, Mikulska, Malgorzata, Montejo, Jose Miguel, Montero, Milagros, Paz Morales, Hugo Manuel, Morales, Isabel, Novo, Andres, Oltolini, Chiara, Peghin, Maddalena, Luis del Pozo, Jose, Puerta-Alcalde, Pedro, Ruiz-Camps, Isabel, Resat Sipahi, Oguz, Tilley, Robert, Yanez, Lucrecia, Ribeiro Gomes, Marisa Zenaide, Carratala, Jordi, Cuervo, Guillermo, Escrihuela-Vidal, Francesc, Tubau, Fe, Rodriguez Arias, Marisol, Merve Ayaz, Caglayan, Munita, Jose, Gasch, Oriol, Capilla, Silvia, Bochud, Pierre-Yves, Manuel, Oriol, Torre-Cisneros, Julian, Tabares, Salvador, Serrano Lopez, Josefina, Maschmeyer, Georg, Torres, Diego, Abdala, Edson, Bittencourt, Driele Peixoto, El Zein, Saeed, Jabbour, Jean-Francois, Bertz, Hartmut, Peyerl-Hoffmann, Gabriele, Lizasoain, Manuel, Maria Aguado, Jose, Clemencia Correa, Lina, Palop, Begona, Fortun, Jesus, Magnasco, Laura, Cespedes, Roberto, Lopez-Soria, Leire, Pablo Horcajada, Juan, Montaguti, Mia Hold, de Cueto, Marina, Rodriguez-Bano, Jesus, Greco, Raffaella, Cichero, Paola, Bassetti, Matteo, Castaldo, Nadia, Sangro del Alcazar, Paloma, Cardozo, Celia, Garcia-Vidal, Carolina, Aguilar-Company, Juan, Larrosa, Nieves, Uyan-Onal, Ayse, Nazli-Zeka, Arzu, Vasconcelos de Freitas, Wania, da Silva Machado, Amanda Aparecida, IRONIC Study Grp

المساهمون: Instituto de Salud Carlos III, Ministerio de Economía, Industria y Competitividad (España), European Commission, IRONIC study group, Cuervo, G., Escrihuela-Vidal, F., Arias, M.R., Ayaz, C.M., Munita, J., Gasch, O., Bochud, P.Y., Manuel, O., Torres, D., Zein, S.E., Jabbour, J.F., Bertz, H., Peyerl-Hoffmann, G., Lizasoain, M., Aguado, J.M., Palop, B., Fortún, J., Maschmeyer, G., Magnasco, L., Céspedes, R., López-Soria, L., Horcajada, J.P., Montaguti, M.H., Cueto, M., Rodríguez-Baño, J., Greco, R., Cichero, P., Bassetti, M., Castaldo, N., Del Alcázar, P.S., Cardozo, C., Garcia-Vidal, C., Aguilar-Company, J., Larrosa, N., Uyan-Onal, A., Nazli-Zeka, A., Eylul, D., Turkey, I., Clemencia Correa, L., de Freitas, W.V., da Silva Machado, A.A., Institut Català de la Salut, [Albasanz-Puig A, Gudiol C] Departament de Malalties Infeccioses, Hospital Universitari de Bellvitge, Barcelona, Spain. Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain. Universitat de Barcelona, Barcelona, Spain. Spanish Network for Research in Infectious Diseases (REIPI), Instituto de Salud Carlos III, Madrid, Spain. [Parody R] Departament d’hematologia, Institut Català d' Oncologia (ICO) Barcelona, Spain. Hospital Duran i Reynals, Barcelona, Spain. . Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain. [Tebe C] Servei d’estadística, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain. Universitat Rovira i Virgili, Barcelona, Spain. [Akova M] Infectious Diseases Department, Hacettepe University School of Medicine, Ankara, Turkey. [Araos R] Infectious Diseases Department, Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina, Clínica Alemana, Universidad del Desarrollo, Santiago de Chile, Chile. [Ruiz-Camps I] Servei de Malalties Infeccioses, Hospital Universitari Vall d'Hebron, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus, Ege Üniversitesi

المصدر: Dipòsit Digital de la UB
Universidad de Barcelona
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Digital.CSIC. Repositorio Institucional del CSIC
instname
BMJ open, vol. 9, no. 5, pp. e025744
Recercat. Dipósit de la Recerca de Catalunya
Scientia

مصطلحات موضوعية: Microbiological Phenomena::Drug Resistance, Microbial [PHENOMENA AND PROCESSES], Research design, infecciones bacterianas y micosis::infecciones bacterianas y micosis::infección::sepsis::bacteriemia [ENFERMEDADES], bacteraemia, Time Factors, modelos logísticos, International Cooperation, humanos, resistencia a medicamentos, Drug Resistance, Bacteremia, Bacteria::bacterias gramnegativas::bacterias aerobias gramnegativas::bacilos y cocos aerobios gramnegativos::Pseudomonadaceae::Pseudomonas::Pseudomonas aeruginosa [ORGANISMOS], bloodstream infection, multidrug-resistant, neutropenia, onco-haematological patients, pseudomonas aeruginosa, estudios multicéntricos como asunto, Bacterièmia, 0302 clinical medicine, Bacteria::Gram-Negative Bacteria::Gram-Negative Aerobic Bacteria::Gram-Negative Aerobic Rods and Cocci::Pseudomonadaceae::Pseudomonas::Pseudomonas aeruginosa [ORGANISMS], Drug Resistance, Multiple, Bacterial, Neoplasms, Clinical endpoint, Onco-haematological patients, Multicenter Studies as Topic, Multidrug-resistant, Microorganismes - Resistència als medicaments, Otros calificadores::Otros calificadores::/inmunología [Otros calificadores], 030212 general & internal medicine, neoplasias, 0303 health sciences, Neutropènia, fenómenos microbiológicos::farmacorresistencia microbiana [FENÓMENOS Y PROCESOS], Incidence (epidemiology), bacteriemia, General Medicine, Bacterial Infections and Mycoses::Bacterial Infections and Mycoses::Infection::Sepsis::Bacteremia [DISEASES], Anti-Bacterial Agents, Malalts de càncer, Observational Studies as Topic, Research Design, Pseudomonas aeruginosa, Ceftolozane, antibacterianos, medicine.drug, medicine.medical_specialty, Tazobactam, Neutropenia, Pseudomones aeruginosa, Bloodstream infection, 03 medical and health sciences, factores de tiempo, Other subheadings::Other subheadings::/immunology [Other subheadings], Internal medicine, Pseudomonas, medicine, Humans, Pseudomonas Infections, Anti-Bacterial Agents/therapeutic use, Bacteremia/drug therapy, Bacteremia/mortality, Cephalosporins/therapeutic use, Logistic Models, Neoplasms/complications, Neutropenia/complications, Pseudomonas Infections/drug therapy, Pseudomonas aeruginosa/isolation & purification, Retrospective Studies, Tazobactam/therapeutic use, Resistència als medicaments, infecciones por Pseudomonas, cefalosporinas, 030306 microbiology, business.industry, estudios retrospectivos, enfermedades hematológicas y linfáticas::enfermedades hematológicas::trastornos leucocitarios::leucopenia::agranulocitosis::neutropenia [ENFERMEDADES], cooperación internacional, Retrospective cohort study, Cancer patients, medicine.disease, Cephalosporins, Drug resistance, Hemic and Lymphatic Diseases::Hematologic Diseases::Leukocyte Disorders::Leukopenia::Agranulocytosis::Neutropenia [DISEASES], Bacteraemia, Observational study, business, diseño de la investigación

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdb29f0d53be1e42baa4010859f28bf8
https://doi.org/10.1136/bmjopen-2018-025744

المؤلفون: Sarah Thorning, An De Sutter, Mieke L van Driel, Hilde Habraken, Thierry Christiaens

المصدر: The Cochrane Library
Cochrane Database Syst Rev
COCHRANE DATABASE OF SYSTEMATIC REVIEWS

مصطلحات موضوعية: 0301 basic medicine, CEFUROXIME AXETIL, Azithromycin, Macrolides [therapeutic use], law.invention, BETA-HEMOLYTIC STREPTOCOCCI, 0302 clinical medicine, Randomized controlled trial, law, Ampicillin, Cephalosporins [therapeutic use], Medicine and Health Sciences, Sore throat, Medicine, Pharmacology (medical), 030212 general & internal medicine, Pharyngitis [drug therapy, Child, Randomized Controlled Trials as Topic, Aged, 80 and over, Sulfonamides, Penicillins [therapeutic use], Clindamycin, Pharyngitis, RANDOMIZED CONTROLLED-TRIAL, Middle Aged, Anti-Bacterial Agents, microbiology], ONCE-DAILY AMOXICILLIN, Child, Preschool, Number needed to treat, Macrolides, ACUTE SORE THROAT, medicine.symptom, Clindamycin [therapeutic use], medicine.drug, Adult, Medicine General & Introductory Medical Sciences, medicine.medical_specialty, Anti-Bacterial Agents [therapeutic use], Adolescent, 5-DAY CEFDINIR TREATMENT, Streptococcus pyogenes, 030106 microbiology, 10-DAY AMOXICILLIN TREATMENT, Ampicillin [therapeutic use], Penicillins, Young Adult, 03 medical and health sciences, Streptococcal Infections, Internal medicine, Humans, Intensive care medicine, Aged, Sulfonamides [therapeutic use], business.industry, Streptococcal Infections [drug therapy, RHEUMATIC-FEVER, Amoxicillin, Infant, INTRAMUSCULAR BENZATHINE PENICILLIN, COMPARATIVE EFFICACY, Cephalosporins, Clinical trial, Penicillin, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::890e3a3313843be24ab9ebb73591642d
https://doi.org/10.1002/14651858.cd004406.pub4

المؤلفون: Kurt G. Naber, Frieder Kees, Horst Grobecker

مصطلحات موضوعية: Microbiology (medical), Adult, Male, medicine.medical_specialty, Nausea, Urinary system, Ceftazidime, Bacterial Infections/drug therapy, Gastroenterology, Cephalosporins/therapeutic use, Pharmacokinetics, 615 Pharmazie, Internal medicine, medicine, Humans, Pharmacology (medical), In patient, Aged, Pharmacology, Kidney, business.industry, Bacterial Infections, Middle Aged, Rash, ddc:615, Cephalosporins, Surgery, Diarrhea, Kinetics, Infectious Diseases, medicine.anatomical_structure, Urinary Tract Infections, Female, medicine.symptom, Urinary Tract Infections/drug therapy, business, medicine.drug, Half-Life

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69d1ab0a808c01d2f29054602ed1fcb5